|
Resverlogix Expands Phase 2b Clinical Trial for COVID-19
|
8
|
Resverlogix Corp.
|
Feb 17, 2022 07:19AM
|
|
RESVERLOGIX CORP.CODE OF BUSINESS CONDUCT AND ETHICS
|
1
|
Resverlogix Corp.
|
Sep 12, 2019 03:03PM
|
|
Resverlogix Announces Voting Results from the 2024 Meeting of Shareholders and Closing of Debenture Extension
|
3
|
Resverlogix Corp.
|
Jul 31, 2024 06:42PM
|
|
Resverlogix Announces Voting Results from the 2023 Meeting of Shareholders
|
2
|
Resverlogix Corp.
|
Jun 20, 2023 07:45PM
|
|
RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
2
|
Resverlogix Corp.
|
Jun 22, 2022 04:38AM
|
|
Resverlogix Announces Publication of its 40th Scientific Journal Article on Apabetalone's Potential Therapeutic Benefits
|
4
|
Resverlogix Corp.
|
Jan 11, 2024 07:55AM
|
|
Resverlogix Announces One-Year Extension of Debenture
|
2
|
Resverlogix Corp.
|
Apr 19, 2022 05:08PM
|
|
Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
4
|
Resverlogix Corp.
|
Jun 12, 2023 07:23AM
|
|
Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes
|
2
|
Resverlogix Corp.
|
Aug 29, 2023 07:27AM
|
|
Reports of Exempt Distribution
|
1
|
Zenith Epigenetics
|
Feb 04, 2023 09:01AM
|
|
Report Of Exempt Distribution.
|
3
|
Zenith Epigenetics
|
Apr 16, 2024 03:39PM
|
|
Report of exempt distribution on SEDAR
|
2
|
Resverlogix Corp.
|
Sep 10, 2022 06:34AM
|
|
Report of exempt distribution
|
3
|
Resverlogix Corp.
|
Jul 01, 2020 02:12PM
|
|
Report of exempt distribution
|
4
|
Resverlogix Corp.
|
May 07, 2020 01:43PM
|
|
Report of exempt distribution
|
1
|
Resverlogix Corp.
|
Nov 10, 2020 03:53PM
|
|
Replace "Stroke Mace" with "CHF Mace"
|
5
|
Resverlogix Corp.
|
Nov 18, 2019 09:11AM
|
|
Regeneron drug saves lives in severe COVID-19, but it’s not for all
|
1
|
Resverlogix Corp.
|
Jun 16, 2021 10:23AM
|
|
Recent Funding - Zenith CC
|
3
|
Zenith Epigenetics
|
Oct 21, 2022 02:04PM
|
|
Reaching 250 MACE
|
|
Resverlogix Corp.
|
Apr 23, 2019 11:03AM
|
|
Re: So what's our ceo's next move/plan? one thought ...
|
2
|
Resverlogix Corp.
|
Apr 25, 2023 04:38PM
|
